NEW YORK — 23andMe has raised $82.5 million through an equity sale, according to a filing late last week with the US Securities and Exchange Commission.
According to the filing, 23andMe offered a total of $85 million worth of equity.
The firm confirmed that the Series F round was led by Sequoia Capital and NewView Capital, which was reported yesterday by Bloomberg.
In January, the Sunnyvale, California-based direct-to-consumer genetic test developer and ancestry information firm laid off about 100 of its employees — roughly 14 percent of its workforce at the time — amid a restructuring of its consumer business.
In mid-2018, 23andMe raised about $300 million in an equity offering. The year before, the company closed an approximately $250 million financing round led by Sequoia Capital.